Linical Co., Ltd. engages in pharmaceutical contract research projects providing consulting, monitoring, and quality control services to pharmaceutical companies. It operates through the Contract Research Organization (CRO) and Pharmaceutical business segments. The CRO business segment provides outsourced pharmaceutical development services. The Pharmaceutical business segment handles marketing support on products of the pharmaceutical companies. The company was founded by Kazuhiro Hatano on June 7, 2005 and is headquartered in Osaka, Japan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company